
|Articles|August 16, 2019
Improving the Economic Burden of Ankylosing Spondylitis: Targeting IL-17/IL-23 Pathways
Advertisement
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
TrumpRx Launch Brings Savings—and Uncertainty
2
5 Things to Know About the Oral GLP-1 Era
3
Exploring Identity, Appearance Experiences Among Patients With Alopecia
4
Asundexian Reduces Risk of Stroke Recurrence in Phase 3 OCEANIC-STROKE Trial
5









